Infectious Disease News of the Week
January 19th 2024This week: Insights into the comparative analysis of COVID and non-COVID pneumonia; how myopathy, with metabolic disturbances and amyloid deposits, is discovered in persons with Long COVID who experience post-exertional malaise; and the Pfizer COVID-19 vaccine is shown to be effective in children and adolescents.
Reducing the Burden and Making Progress in Hepatitis C and Kidney Disease
January 17th 2024The Kidney Disease: Improving Global Outcomes (KDIGO) work group has published updated guidelines in the Annals of Internal Medicine for the prevention, diagnosis, evaluation, and treatment of HCV in CKD patients.
HBV Markers, Reactivation Do Not Impact Effectiveness of Direct-Acting Antivirals for HCV
January 16th 2024Response to direct-acting antiviral therapy was similar between patients with and without HBV coinfection, with most patients completing the planned course of treatment and achieving SVR, even in the case of HBV reactivation.
Black Patients Receive Less HAI Testing Despite Similar Positivity Rates to White Patients
January 15th 2024A retrospective cohort study of inpatient encounters from 3 hospitals in the Duke University Health System showed greater rates of testing among White patients compared to Black and NWNB patients.
Infectious Disease: This Week's News
January 13th 2024This week's news includes emerging treatment options for patients with persistently positive blood cultures with Methicillin-Susceptible Staphylococcus aureus; how the development of antimicrobial stewardship programs can be an effective strategy for beginning to reduce this critical timing for patients in ICUs; a look at another antibiotic being studied for a healthcare-associated infection; and an investigational vaccine against the Nipah virus begins.
DAAs Reduce Iron Parameters in Patients with Hepatitis C, Hyperferritinemia
January 8th 2024Statistically significant reductions in serum ferritin, transferrin saturation index, and iron levels were observed after treatment, with hyperferritinemia eradicated in nearly all patients treated with DAAs achieving SVR.